N-terminal-pro-B-type natriuretic peptide testing reduced duration of ED visits in patients presenting with dyspnea

November 2007
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p62
Academic Journal
The article offers information on a study that investigates the use of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) testing to improve management, in dyspnea patients presenting to the emergency department (ED). It describes the setting, patients' condition, and randomized controlled trial (RCT) that was carried out during the study. The study revealed that the patients treated with NT-proBNP had reduced the cost and visits to emergency department, and improved diagnostic accuracy.


Related Articles

  • The good and the ugly: ANP antagonizes the deleterious effects of aldosterone in hypertensive cardiac remodeling. Nakagawa, Hitoshi; Völker, Katharina; Oberwinkler, Heike; Gaßner, Birgit; Dienesch, Charlotte; Umbenhauer, Sandra; Baba, Hideo A.; Frantz, Stefan; Kuhn, Michaela // BMC Pharmacology & Toxicology; 

    An abstract of the paper "The good and the ugly: Atrial natriuretic peptide antagonizes the deleterious effects of aldosterone in hypertensive cardiac remodeling" presented at the 6th International Conference on cGMP held in Germany in June 2013 is presented.

  • BACH: MRproANP, MRproADM plus BNP improved acute HF diagnoses.  // Cardiology Today;Jun2010, Vol. 13 Issue 6, p22 

    The article focuses on a study about the impact of combining midregional pro-atrial natriuretic peptide with B-type natriuretic peptide on the diagnosis of acute heart failure (HF) which was published in an issue of the "Journal of the American College of Cardiology."

  • Dissecting the genetics of complex traits: lessons from hypertension*. Navis, Gerjan; Bakker, Stephan J. L.; van der Harst, Pim // Nephrology Dialysis Transplantation;May2010, Vol. 25 Issue 5, p1382 

    The article offers information on the research conducted to evaluate the correlation between atrial natriuretic peptides (ANP), brain natriuretic peptides (BNP) and blood pressure of patients in Groningen, Netherlands. Researchers did the study on 1705 subjects with higher ANP and BNP levels and...

  • Review: multiple doses of antenatal corticosteroids prevent preterm neonatal respiratory disease more than a single dose. Crowther, C. // Evidence Based Medicine;Jun2008, Vol. 13 Issue 3, p81 

    QUESTION In women at risk of preterm birth, what is the effectiveness and safety of multiple doses of antenatal corticosteroids (ACSs) compared with a single dose for preventing neonatal respiratory disease? REVIEW SCOPE Studies comparing repeat dose(s) of ACSs with placebo or no treatment for...

  • Clinical Pharmacists on Medical Care of Pediatric Inpatients: A Single-Center Randomized Controlled Trial Zhang, Chuan; Zhang, Lingli; Huang, Liang; Luo, Rong; Wen, Jin // PLoS Clinical Trials;Jan2012, Vol. 7 Issue 1, p1 

    Objective: To explore the best interventions and working patterns of clinical pharmacists in pediatrics and to determine the effectiveness of clinical pharmacists in pediatrics. Methods: We conducted a randomized controlled trial of 160 pediatric patients with nerve system disease,...

  • Research in progress: put the orphanage out of business. Bush, Andrew; Anthony, Gisela; Barbato, Angelo; Cunningham, Steve; Clement, Annick; Epaud, R.; Gilbert, Carlee; Goldbeck, Lutz; Kronfeld, Kai; Nicholson, Andrew G.; Schwerk, Nicolaus; Griese, Matthias // Thorax;Oct2013, Vol. 68 Issue 10, p971 

    Paediatric interstitial lung disease (ILD) is rare and diverse, meaning no single centre will see sufficient children to perform the studies needed to make progress. This EU FP-7 grant will standardise the evaluation of these rare conditions by establishing pan- European multidisciplinary expert...

  • Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial. Reddel, Helen K.; Belousov, Elena G.; Marks, Guy B.; Jenkins, Christine R. // Primary Care Respiratory Journal;Mar2008, Vol. 17 Issue 1, p39 

    Aim: To compare the effects of fluticasone and placebo on asthma control in patients with mild asthma. Method: Adults with FEV1 >80% predicted and reliever use ≤2 times/week were randomised to receive fluticasone 250 mcg/day or placebo double-blind for 11 months. Exacerbations were treated...

  • Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. Farquhar, Morag C.; Prevost, A. Toby; McCrone, Paul; Brafman-Price, Barbara; Bentley, Allison; Higginson, Irene J.; Todd, Chris; Booth, Sara // BMC Medicine;2014, Vol. 12 Issue 1, p1 

    Background Breathlessness is common in advanced cancer. The Breathlessness Intervention Service (BIS) is a multi-disciplinary complex intervention theoretically underpinned by a palliative care approach, utilising evidence-based non-pharmacological and pharmacological interventions to support...

  • Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Chung-Jung Liu; Yi-Chang Cheng; Kung-Wei Lee; Hsi-Hsien Hsu; Chun-Hsien Chu; Fuu-Jen Tsai; Chang-Hai Tsai; Chia-Yih Chu; Jer-Yuh Liu; Wei-Wen Kuo // Molecular & Cellular Biochemistry;Jun2008, Vol. 313 Issue 1/2, p167 

    Abstract  Evidences suggest that lipopolysaccharide (LPS) participates in the inflammatory response in the cardiovascular system; however, it is unknown if LPS is sufficient to cause the cardiac hypertrophy. In the present study, we treated H9c2 myocardiac cells with LPS to explore whether...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics